The Food and Drug Administration has put in for a $7.2 billion chunk of the $6.9 trillion federal budget for fiscal year 2024 that President Joe Biden proposed March 9.

"Margins are not expected to return to pre-pandemic levels for quite some time," according to a new report.

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more. 

Industry giant Abbott estimated that the new test could reduce the number of unnecessary computed tomography scans by up to 40%.

West Fargo, North Dakota-headquartered DMS Health Technologies is acquiring the assets of Advanced Imaging Management, bolstering its MRI and ultrasound offerings.  

Biden says his proposals are an extension of what he has already accomplished to reduce the deficit and lower healthcare spending.

Failure to act could prove detrimental to physicians and their patients, ACR and similar groups representing anesthesiologists and emergency providers argued. 

Each of the new “state of the art” facilities will stand at about 5,750 square feet, staffed by doctors and offering the full gamut of healthcare services.